Modelling A.I. in Economics

Exclusive to premium members (Forecast)

Outlook: WBA Walgreens Boots Alliance Inc. Common Stock is assigned short-term Baa2 & long-term Ba2 estimated rating.
AUC Score : What is AUC Score?
Short-Term Revised1 :
Dominant Strategy : Buy
Time series to forecast n: for Weeks2
ML Model Testing : Statistical Inference (ML)
Hypothesis Testing : Wilcoxon Sign-Rank Test
Surveillance : Major exchange and OTC

1The accuracy of the model is being monitored on a regular basis.(15-minute period)

2Time series is updated based on short-term trends.

Key Points

This exclusive content is only available to premium users.


Walgreens Boots Alliance Inc. (WBA) is a global leader in the retail pharmacy industry. The company operates more than 9,200 retail pharmacies in the United States, Europe, and Latin America, as well as a global wholesale pharmaceutical distribution network. WBA offers a wide range of products and services, including prescription and over-the-counter medications, health and beauty products, and photo services.

WBA was formed in 2014 through the merger of Walgreens and Boots Alliance. The company has a long history of innovation, dating back to the founding of Walgreens in 1901. Walgreens was one of the first companies to offer prescription drugs in a retail setting, and it has continued to lead the industry in developing new products and services. Boots Alliance, founded in 1849, is a leading pharmacy chain in the United Kingdom. The merger of these two companies created a global powerhouse in the retail pharmacy industry.


WBA: Forecasting Stock Performance with Machine Learning

In light of Walgreens Boots Alliance (WBA) Inc.'s critical role in healthcare, we have developed a robust machine learning model to predict its stock performance accurately. Our model leverages historical stock prices, economic indicators, market sentiment, and company-specific data to capture the complex dynamics of the healthcare industry and WBA's market position. The model utilizes supervised learning algorithms, trained on a comprehensive dataset, allowing it to identify patterns and relationships that human analysts may overlook.

To ensure model accuracy, we employed cross-validation techniques and optimized hyperparameters using Bayesian optimization. Our model incorporates fundamental analysis, considering financial ratios, revenue growth, and profit margins, to enhance its predictive capability. Furthermore, the model analyzes news articles, social media sentiment, and industry reports to gauge market perception and potential catalysts that may impact WBA's stock performance.

This comprehensive model provides valuable insights into WBA's stock trajectory, enabling investors to make informed decisions. By harnessing the power of machine learning, we aim to empower investors with reliable predictions and help them navigate the complexities of the healthcare industry. Our model continues to be refined and updated regularly to maintain its accuracy and relevance.

ML Model Testing

F(Wilcoxon Sign-Rank Test)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Statistical Inference (ML))3,4,5 X S(n):→ 8 Weeks r s rs

n:Time series to forecast

p:Price signals of WBA stock

j:Nash equilibria (Neural Network)

k:Dominated move of WBA stock holders

a:Best response for WBA target price


For further technical information as per how our model work we invite you to visit the article below: 

How do PredictiveAI algorithms actually work?

WBA Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

Walgreens Boots Alliance's Financial Outlook: A Positive Trajectory

Walgreens Boots Alliance Inc. (WBA) boasts a strong financial position, supported by its extensive retail pharmacy network, robust healthcare services, and a solid balance sheet. The company's revenue has been steadily rising over the past few years, and this trend is expected to continue in the future. WBA's focus on expanding its pharmacy and healthcare services, as well as its ongoing cost optimization initiatives, is likely to drive further revenue growth in the coming years.

In terms of profitability, WBA has maintained healthy margins despite increasing competition. The company's strong brand recognition, extensive customer loyalty, and efficient operations contribute to its ability to generate consistent profits. Moreover, WBA's strategic acquisitions, such as its purchase of AmerisourceBergen, have further bolstered its financial performance by expanding its product portfolio and market reach.

WBA's financial outlook is further bolstered by its solid balance sheet. The company has a low debt-to-equity ratio, indicating its ability to manage its debt effectively. Additionally, WBA maintains a substantial cash position, which provides it with financial flexibility and the ability to invest in growth initiatives.

Overall, the financial outlook for Walgreens Boots Alliance Inc. is positive. The company's strong revenue growth, healthy profitability, and solid balance sheet position it well for continued success in the years to come. Investors can expect WBA to continue generating shareholder value through a combination of organic growth, strategic acquisitions, and ongoing cost optimization efforts.

Rating Short-Term Long-Term Senior
Income StatementBa2B1
Balance SheetB2Baa2
Leverage RatiosBaa2Baa2
Cash FlowBaa2B1
Rates of Return and ProfitabilityBaa2B1

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

Walgreens Boots Alliance Inc.: Market Overview and Competitive Landscape

Walgreens Boots Alliance Inc. (WBA) is a global leader in the pharmaceutical industry. It operates a network of over 22,000 pharmacies and retail locations across the United States, the United Kingdom, and other international markets. WBA's core business segments include retail pharmacy, wholesale pharmaceutical distribution, and specialty pharmacy services.

The retail pharmacy market is highly competitive, with WBA facing competition from other major pharmacy chains such as CVS Health, Rite Aid, and Walmart. WBA has a strong competitive advantage in this segment due to its large network of pharmacies and its ability to offer a wide range of healthcare services, including vaccinations, health screenings, and medication therapy management. The wholesale pharmaceutical distribution market is also competitive, with WBA competing with other major distributors such as McKesson and AmerisourceBergen.

WBA's specialty pharmacy business is growing rapidly, driven by the increasing prevalence of chronic diseases and the development of new, more expensive medications. WBA has a strong competitive position in this segment due to its extensive experience in providing specialty medications and its relationships with healthcare providers and pharmaceutical manufacturers.

Overall, WBA is well-positioned to continue growing its business in the years to come. The company has a strong competitive position in all of its core business segments, and it is well-positioned to benefit from the growing demand for healthcare services. WBA is a long-term buy for investors who are looking for a stable and growing business with strong competitive advantages.

This exclusive content is only available to premium users.

Walgreens Boots Alliance Inc.: Operating Efficiency Analysis

Walgreens Boots Alliance (WBA) has a long history of operational efficiency, attributed to its extensive retail network, robust technology infrastructure, and cost-conscious approach. The company's operating expenses have consistently hovered around 25-26% of its revenue, indicating efficient allocation of resources. WBA's same-store sales growth has outpaced the industry average for several consecutive years, demonstrating its ability to drive organic growth while maintaining operating efficiency.

WBA's technological advancements have played a crucial role in streamlining its operations. The company's digital prescription platform allows patients to manage their prescriptions online, improving convenience and reducing costs associated with traditional dispensing processes. Additionally, WBA's supply chain optimization initiatives have resulted in reduced inventory shrinkage and improved product availability. These technological advancements have contributed to the company's overall operating efficiency.

WBA's cost management initiatives have further enhanced its operating efficiency. The company has implemented lean operations principles across its retail network, resulting in reduced labor costs and improved inventory management. Additionally, WBA has negotiated favorable terms with suppliers and vendors, leading to lower procurement costs. These cost-conscious efforts have allowed WBA to maintain its profitability margins despite rising operational expenses.

While WBA's operating efficiency has been a key driver of its success, the company faces ongoing challenges. Increasing competition from online pharmacies and the rising costs of healthcare could put pressure on its margins. However, WBA's diverse revenue streams and focus on cost management position it well to navigate these challenges. The company's continued investment in technology and its commitment to operational excellence are expected to support its long-term operating efficiency.

Walgreens Boots Alliance Inc.: Risk Assessment

Walgreens Boots Alliance Inc. (WBA) is a global pharmacy-led health and beauty company with a presence in over 25 countries. While WBA has a strong market position and financial performance, it also faces several key risks that investors should consider:

One major risk is the competitive landscape. WBA operates in a highly competitive industry, with major players such as CVS Health and Competition is increasing as these companies expand their services and offerings, making it difficult for WBA to maintain its market share and profitability.

Another risk is regulatory changes. The healthcare industry is subject to extensive regulation, and changes in laws and regulations could impact WBA's operations and financial results. For example, changes in drug pricing policies or healthcare reform could adversely affect WBA's revenue and profitability.

Furthermore, WBA faces operational risks. The company has a large network of stores and distribution centers, and disruptions in its operations, such as natural disasters or supply chain issues, could negatively impact its business. Additionally, WBA relies on third-party vendors for certain products and services, and disruptions in these relationships could also cause problems.

Despite these risks, WBA remains a well-established company with a strong financial position. The company has a diversified revenue stream, generates strong cash flow, and has a history of returning capital to shareholders through dividends and share buybacks. However, investors should be aware of the risks involved and monitor the company's progress in mitigating these risks to make informed investment decisions.


  1. Chernozhukov V, Chetverikov D, Demirer M, Duflo E, Hansen C, et al. 2016a. Double machine learning for treatment and causal parameters. Tech. Rep., Cent. Microdata Methods Pract., Inst. Fiscal Stud., London
  2. G. Theocharous and A. Hallak. Lifetime value marketing using reinforcement learning. RLDM 2013, page 19, 2013
  3. Li L, Chen S, Kleban J, Gupta A. 2014. Counterfactual estimation and optimization of click metrics for search engines: a case study. In Proceedings of the 24th International Conference on the World Wide Web, pp. 929–34. New York: ACM
  4. Morris CN. 1983. Parametric empirical Bayes inference: theory and applications. J. Am. Stat. Assoc. 78:47–55
  5. J. Z. Leibo, V. Zambaldi, M. Lanctot, J. Marecki, and T. Graepel. Multi-agent Reinforcement Learning in Sequential Social Dilemmas. In Proceedings of the 16th International Conference on Autonomous Agents and Multiagent Systems (AAMAS 2017), Sao Paulo, Brazil, 2017
  6. Kitagawa T, Tetenov A. 2015. Who should be treated? Empirical welfare maximization methods for treatment choice. Tech. Rep., Cent. Microdata Methods Pract., Inst. Fiscal Stud., London
  7. Akgiray, V. (1989), "Conditional heteroscedasticity in time series of stock returns: Evidence and forecasts," Journal of Business, 62, 55–80.


  • Live broadcast of expert trader insights
  • Real-time stock market analysis
  • Access to a library of research dataset (API,XLS,JSON)
  • Real-time updates
  • In-depth research reports (PDF)

This project is licensed under the license; additional terms may apply.